Acute Myeloid Leukemia: Diagnosis and Evaluation by Flow Cytometry
Cancers · 17.11.2024 · 16 (22) · 3855
DOI: 10.3390/cancers16223855 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 17.11.2024. Verfasst von Feras Ally und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA 98195, USA. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 147 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
With recent technological advances and significant progress in understanding the pathogenesis of acute myeloid leukemia (AML), the updated fifth edition WHO Classification (WHO-HAEM5) and the newly introduced International Consensus Classification (ICC), as well as the European LeukemiaNet (ELN) recommendations in 2022, require the integration of immunophenotypic, cytogenetic, and molecular data, alongside clinical and morphologic findings, for accurate diagnosis, prognostication, and guiding therapeutic strategies in AML. Flow cytometry offers rapid and sensitive immunophenotyping through a multiparametric approach and is a pivotal laboratory tool for the classification of AML, identification of therapeutic targets, and monitoring of measurable residual disease (MRD) post therapy. The association of immunophenotypic features and recurrent genetic abnormalities has been recognized and applied in informing further diagnostic evaluation and immediate therapeutic decision-making. Recently, the evolving role of machine learning models in assisting flow cytometric data analysis for the automated diagnosis and prediction of underlying genetic alterations has been illustrated.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA 98195, USA.
- Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.
Zitieren
APA
Ally, F., & Chen, X. (2024). Acute Myeloid Leukemia: Diagnosis and Evaluation by Flow Cytometry. Cancers, 16(22), 3855. https://doi.org/10.3390/cancers16223855
Vancouver
Ally F, Chen X. Acute Myeloid Leukemia: Diagnosis and Evaluation by Flow Cytometry. Cancers. 2024;16(22):3855. doi:10.3390/cancers16223855
BibTeX
@article{Ally2024,
author = {Ally, Feras and Chen, Xueyan},
title = {Acute Myeloid Leukemia: Diagnosis and Evaluation by Flow Cytometry},
journal = {Cancers},
year = {2024},
volume = {16},
number = {22},
pages = {3855},
doi = {10.3390/cancers16223855}
}
EUVIMED